Journal of the American Medical Directors Association
Original StudyImplementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes
Keywords
Cited by (0)
This work was supported The Netherlands Organization for Health Research and Development (ZonMw, program Antibiotic Resistance, grant number 541001 004).
LB reports a grant from The Netherlands Organization for Health Research and Development (ZonMw, program Antibiotic Resistance, grant number 541001 004), for the conduct of the current study. TB, FS, CH, RH and MT have no competing interests to disclose. TV reports grants from Abbott, Becton Dickinson, Biomerieux, European Commission, grants from European Commission, Orion, during the conduct of the study; grants from European Commission, Janssen Pharmaceuticals, grants from ZonMw, outside the submitted work. The Medical Ethical Committee of the VU University medical center in Amsterdam approved the trial protocol on March 28, 2018, as well as participation of all recruitment sites (NHs) in the trial. The trial was registered at the Netherlands Trial Register on 29 August 2018 with trial number NL5054. Orion Diagnostica and Saltro made in total 20 CRP POCT instruments available for the study.